Centrus Energy — Blitz Index 35 (D)

The bottleneck utility — dependent on Russian supply while selling the alternative.

Score breakdown

Radar axes (0–100): Moat 30 · Speed 60 · Creative 67.

Watch item

Gates: G1 conditional pass · G2 pass (estimated, mid confidence). First scored. Chapter 11 in 2014 (as USEC) — historical context. The 'reserve candidate' verdict: bottleneck utility, not a blitz.

Strengths

• $900M DOE task orders, milestone-funded, back execution
• Antares·Radiant HALEU contracts with prepayments funding capex — the fuel version of 'customer money'
• First commercial HALEU from Piketon targeted 2029
• SWU contracts running to 2040 lock in the base business

Concerns

• Growth has stalled (+1.5%); Piketon is slow — money raised, construction not started
• Backlog partly contingent on financing; $4.5B (press) vs $3.7B (SEC) unreconciled
• Russian export permits + Canadian transport permits (to 2027-03) — the thesis fights itself
• Technical Solutions margin −7.5% in Q2 2026

Research notes

1. Current Position

Centrus is **not a company running a blitz but a company stockpiling the blitz's fuel**. The 35/D score is the score of a "strategic bottleneck utility" — not a misjudgment but a classification. Read the financial fingerprint: FY2020 revenue $247M → FY2025 $449M (5-year CAGR ~12.7%), with FY2025 growth of only +1.5% (a sharp deceleration from FY2024's +38%), and H1 2026 +11.1% YoY rebounding. Sustained GAAP profitability (H1 2026 net income of $26.8M), revenue per employee of ~$0.96M, and capex at just 4.4% of revenue — **the exact opposite of the blitz financial fingerprint** (high growth + deliberate losses + capex ≥ revenue). The round-1 discovery classification as a "reserve candidate" was right — this company's core business is a mature, City-stage utility.

2. Blitzscaling Lens

**Rule 8. Raise Too Much Money — blitz-style raising, utility-style spending.** Centrus is the paradox of Rule 8. 2025 converts of $782.4M + $523.7M of common stock, and the September 2026 Guggenheim offering — capital access is top-tier (A2 4 points). But the use of the money is the problem: FY2025 capex was $20M. **$1.3B+ raised through dilution sits in the vault while construction has not begun.** Rule 8 says "running out of money mid-race is fatal, so secure runway even at dilution" — Centrus bought its runway too early and too much of it. The market paid the +27% diluted-share-count price (−71%), and the time value of the money is being paid too. That is the score file's expression: "blitz-style capital raising, utility-style execution." Rule 8 said to raise the money — not to pile it up.

3. Competitive Landscape

**Centrus's enemy is not a competitor but geopolitics.** In the global enrichment market Russia (TENEX) holds 43% — Centrus's business thesis is the substitution of that 43%. Among the three Western enrichers (Urenco·Orano·Centrus), Centrus holds a single-digit global share — an "alternative," not the "substitute." But in HALEU it is America's only commercial production — an irreplaceable strategic position in the new category of SMR fuel. That position is the basis of the DOE $900M task order and the Antares·Radiant·X-energy contracts.

4. Inflection Points

**Inflection Point 1. Completing Piketon expansion financing — resolving the contingent.** What to watch: the financing-structure disclosure (8-K) for the multi-$B capex — whether the combination is DOE support, project financing, or additional equity — and whether the "no assurance" clause disappears from the 10-Q. The moment the contingent character of the $3.7B backlog resolves, G1's conditionality becomes a full PASS. The Fluor EPC contract (2026-02, T&M) is signed — but EPC needs money to run. Link: the representative case of v1.1 candidate 1 ("distinguishing the binding force of contingent backlogs"). The model's direction is that backlogs without completed financing are scored but discounted.

5. One-Line Risk

The Russia to be replaced is the supplier — with TENEX as the largest SWU supplier (through 2028), if the waiver breaks or exports halt, then before domestic production reaches cruising altitude (2029), the company has nothing to sell and nothing to buy. The moment the direct collision between the energy-security thesis and the supply-chain reality resolves is the true blitz's beginning.

1. Current Position

Centrus is **not a company running a blitz but a company stockpiling the blitz's fuel**. The 35/D score is the score of a "strategic bottleneck utility" — not a misjudgment but a classification. Read the financial fingerprint: FY2020 revenue $247M → FY2025 $449M (5-year CAGR ~12.7%), with FY2025 growth of only +1.5% (a sharp deceleration from FY2024's +38%), and H1 2026 +11.1% YoY rebounding. Sustained GAAP profitability (H1 2026 net income of $26.8M), revenue per employee of ~$0.96M, and capex at just 4.4% of revenue — **the exact opposite of the blitz financial fingerprint** (high growth + deliberate losses + capex ≥ revenue). The round-1 discovery classification as a "reserve candidate" was right — this company's core business is a mature, City-stage utility.

Traces of the blitz are confined **to the Piketon/HALEU expansion segment alone**: a multi-$B capex plan, headcount up +45% YoY (322 → 467 employees, Piketon +63%), capital mobilization of $782M in converts (0%/2.25%) + $523.7M in equity + the September 2026 Guggenheim offering (500,000 shares + ~9M warrants), and customer prepayments (HALEU contracts with Antares·Radiant·X-energy). The whole company is not blitzing — one segment is. A single v1.0 score makes it 35/D, but that may be the trap of "the average" (score-file v1.1 candidate 4: dual stages by segment).

But while the fuel is gathered, **the engine has not started**. Expansion financing is incomplete ("no assurance that the Company will successfully complete," 10-Q), the first new centrifuge's start-up target is 2029, and the $3.7B backlog (Q2 2026 10-Q, SEC confirmed) is "partially-contingent" — contracts could be voided if financing is not secured. Blitz-style capital raising but utility-style execution: $1.3B+ raised while FY2025 actual capex was $20M. **The money is piled up and construction has not begun.** The stock's −71% from its high ($464.25 → $135.45) is the price of that gap.

The sharpest thing about this company is its **contradiction**. TENEX (a Rosatom subsidiary) is the largest SWU supplier (contracted through 2028, SEC confirmed) — the company sells the replacement of Russian supply while depending on Russian supply. It leans on DOE waivers under the Import Ban Act (2024-05-13) — approved for 2024–2027 committed volumes — and faces Russian export-license and Canadian transport-license (through 2027-03) risks. This contradiction does not resolve until domestic production reaches cruising altitude — the basis of D4 −2, and the business thesis itself.

There is a bright side. America's only commercial HALEU production (SEC and press agree) — an irreplaceable strategic position. The DOE's $900M HALEU task order (awarded 2026-01-05, firm fixed price, milestone payments, 1 MTU delivered by 2032 + 2 options, SEC confirmed). Long-term SWU contracts (through 2040). A net-cash position (cash $1,957.2M > long-term debt $1,174.8M) — most of the debt is low-coupon converts, i.e., productive financing.

The GATE verdict: G1 is a conditional PASS — the persistence of recognized revenue plus metered contract demand ($3.7B backlog = ~7.8x TTM), conditioned on the expansion financing being incomplete (the same device as the ASTS·CIFR precedents). G2 (10-year ceiling ≥ 10x current revenue, bar ≈ $4.7B) is a PASS (estimate) — global enrichment at ~$7–8B/year plus new HALEU demand, with the U.S. domestic enrichment 10-year ceiling exceeding the bar by 2x or more. But most of the ceiling comes from "substitution" (Russian → American) within existing markets.

**Two-sided assessment (per the score file):** - **On the upside:** America's only commercial HALEU production — an irreplaceable strategic position · the DOE $900M task order (firm fixed price, milestone payments) + confirmed HALEU contracts with Antares·Radiant·X-energy (prepayments included) · backlog of $3.7B (SEC) = ~7.8x TTM, with long-term SWU contracts through 2040 · net-cash position (cash $1,957M > long-term debt $1,175M) with a low-coupon-converts-centered capital structure · headcount +45% YoY — management's bet on expansion. - **On the downside:** FY2025 revenue growth of +1.5% — proven growth deceleration, the speed condition of a blitz unmet · much of the backlog is contingent — contracts could be voided if expansion financing fails · TENEX dependence (largest supplier, through 2028) + waiver dependence — a geopolitical single point of failure · cumulative dilution: diluted share count 17.4M → 22.1M (+27%), plus ~7M common warrants from September as additional potential (~9M total including ~2M pre-funded) · Technical Solutions margin deterioration (Q2 2026 −7.5%) — DOE business profitability in question · the $4.5B backlog claim (press) inconsistent with the SEC's $3.7B — a communications-credibility issue.

The directional assessment is **"the fuel is gathered and the engine is idling"** — the score's direction depends on two distant doors: the completion of Piketon financing and the 2029 start-up. **Atlas v2 classification: ignition in progress (pre-ignition, conditional)** — alongside ASTS·CIFR·FRMI, the contract/recognition ratio forms the quantitative definition of explosion-waiting (LEU: backlog of $3.7B = 7.8x TTM).

2. Blitzscaling Lens

**Rule 8. Raise Too Much Money — blitz-style raising, utility-style spending.** Centrus is the paradox of Rule 8. 2025 converts of $782.4M + $523.7M of common stock, and the September 2026 Guggenheim offering — capital access is top-tier (A2 4 points). But the use of the money is the problem: FY2025 capex was $20M. **$1.3B+ raised through dilution sits in the vault while construction has not begun.** Rule 8 says "running out of money mid-race is fatal, so secure runway even at dilution" — Centrus bought its runway too early and too much of it. The market paid the +27% diluted-share-count price (−71%), and the time value of the money is being paid too. That is the score file's expression: "blitz-style capital raising, utility-style execution." Rule 8 said to raise the money — not to pile it up.

**Rule 5. Let Fires Burn — the real fire is the supply chain; the small fires are margins.** Centrus's true big fire is **the single point of failure called TENEX/waiver**. The largest SWU supplier is a Russian state-owned subsidiary, and the structure survives on waivers under the Import Ban — if sanctions tighten or Russia halts exports, then before domestic production reaches cruising altitude (2029), the company has nothing to sell and nothing to buy. Hoffman's fire priority 1 (Distribution) is exactly here. The small fires: Technical Solutions' margin deterioration (Q2 2026 −7.5%), uranium-trading volatility (FY2025 −54%), and the communications problem of the $4.5B vs $3.7B backlog inconsistency. From Rule 5's view the small fires can be left to burn — except that, since this company's "product" is the trust asset called energy security, a communications inconsistency is not a small fire but a credit fire.

**Rule 1. Embrace Chaos — a company whose 10-Q discloses Plans A/B/Z.** Centrus's 10-Q effectively discloses Plans A/B/Z. Plan A: complete Piketon financing → 2029 start-up → commercial HALEU delivery. Plan B: delayed financing → endure on the legacy LEU segment's long-term contracts (SWU through 2040). Plan Z: waiver cut → supply disruption → the "no assurance" clause made real. Rule 1 says to accept chaos as the default state and decide on incomplete information — Centrus's management is already doing that (betting on expansion while keeping the legacy business profitable). The problem is the market's patience. The stock is not enduring the chaos through 2029.

3. Competitive Landscape

**Centrus's enemy is not a competitor but geopolitics.** In the global enrichment market Russia (TENEX) holds 43% — Centrus's business thesis is the substitution of that 43%. Among the three Western enrichers (Urenco·Orano·Centrus), Centrus holds a single-digit global share — an "alternative," not the "substitute." But in HALEU it is America's only commercial production — an irreplaceable strategic position in the new category of SMR fuel. That position is the basis of the DOE $900M task order and the Antares·Radiant·X-energy contracts.

**The demand-realization timing is coupled to SMR commercialization** (late 2020s). The HALEU market's size is set by the SMR industry's speed — a variable Centrus cannot control. That is the discount factor behind B3 (market size) 6 points. "The market is large" and "the market opens" are different things.

Restating **the structure of the contradiction**: with TENEX as the largest SWU supplier (through 2028), the company sells "the exclusion of Russian supply." The Import Ban's waivers are approved for 2024–2027 committed volumes, but what follows is unconfirmed. The true blitz begins when this contradiction resolves (domestic production at cruising altitude, 2029 onward) — until then, Centrus is closer to "an importer selling the substitute."

4. Inflection Points

**Inflection Point 1. Completing Piketon expansion financing — resolving the contingent.** What to watch: the financing-structure disclosure (8-K) for the multi-$B capex — whether the combination is DOE support, project financing, or additional equity — and whether the "no assurance" clause disappears from the 10-Q. The moment the contingent character of the $3.7B backlog resolves, G1's conditionality becomes a full PASS. The Fluor EPC contract (2026-02, T&M) is signed — but EPC needs money to run. Link: the representative case of v1.1 candidate 1 ("distinguishing the binding force of contingent backlogs"). The model's direction is that backlogs without completed financing are scored but discounted.

**Inflection Point 2. The waiver and TENEX — supply continuity.** What to watch: DOE waiver renewals (post-2027 committed volumes), extensions of the Russian export license and the Canadian transport license (through 2027-03), and whether non-TENEX suppliers are secured. The observation method is tracking the 10-K Risk Factors' wording. Every sanctions-tightening headline moves this inflection point first. Link: D4 −2 is the score of "structural risk in direct collision with the business thesis." If the waiver breaks, D4 heads toward −4 or worse, and simultaneously C1's basis (the Russian-substitution thesis) wobbles — the whole score structure is a linked risk.

**Inflection Point 3. The DOE task order's milestone progress — measured execution.** What to watch: milestone-achievement disclosures for the DOE $900M task order, the milestone-payment receipts, Piketon construction progress, and whether the 2029 start-up target holds. The observation point is the moment construction begins in a state of "the money is piled up and construction has not begun." Also watch whether the Technical Solutions segment's margin (Q2 2026 −7.5%) recovers — if DOE-business profitability is in question, more milestones can mean more losses. Link: B2 (distribution scalability) 5 points is the score of "slow expansion." Commercial HALEU delivery before 2029 is the only path above 5 points.

**Observation checklist (quarterly):** ① whether the Piketon financing structure is disclosed as finalized ② changes in the 10-Q's "no assurance" clause ③ DOE waiver renewals and transport-license extensions ④ DOE task-order milestone achievements and payment receipts ⑤ whether the Technical Solutions margin recovers ⑥ changes in the contingent share of the $3.7B backlog. ①·② are "engine" metrics, ③ is a "survival" metric, ④·⑤·⑥ are "execution" metrics. If the engine never starts, the rest is maintenance.

5. One-Line Risk

The Russia to be replaced is the supplier — with TENEX as the largest SWU supplier (through 2028), if the waiver breaks or exports halt, then before domestic production reaches cruising altitude (2029), the company has nothing to sell and nothing to buy. The moment the direct collision between the energy-security thesis and the supply-chain reality resolves is the true blitz's beginning.

*BlitzLab v1.0 (frozen). Unconfirmed figures must carry estimate/press-reported labels.* *For education and research purposes only. Not a recommendation to buy, sell, or hold any security.*

Site Summary

Centrus is not a company running a blitz but a company stockpiling the blitz's fuel, at 35/D — 30 points below the threshold. The financial fingerprint is the exact opposite of a blitz: FY2020 revenue $247M → FY2025 $449M (5-year CAGR ~12.7%, but FY2025 growth of only +1.5%), sustained GAAP profitability, revenue per employee of ~$0.96M, and capex at just 4.4% of revenue. The core business is a mature, City-stage utility. - The blitz exists only in the Piketon/HALEU expansion segment: a multi-$B capex plan, headcount +45% YoY (322 → 467), capital mobilization of $782M in converts + $523.7M in equity + the September 2026 Guggenheim offering, and customer prepayments (Antares·Radiant·X-energy). But the financing is incomplete ("no assurance," 10-Q), first centrifuge start-up targets 2029, and the $3.7B backlog (SEC) is partially contingent. The money is piled up; construction has not begun. - The sharpest feature is the contradiction: TENEX (a Rosatom subsidiary) is the largest SWU supplier (through 2028, SEC confirmed) while the company sells the replacement of Russian supply. It survives on DOE waivers under the Import Ban Act (2024-05-13), approved for 2024–2027 committed volumes; what follows is unconfirmed. D4 −2 scores this structural risk — in direct collision with the business thesis itself. - The bright side: America's only commercial HALEU production — an irreplaceable strategic position — the DOE $900M task order (firm fixed price, milestone payments, 1 MTU by 2032 + 2 options), long-term SWU contracts through 2040, and a net-cash position ($1,957M cash > $1,175M long-term debt) centered on low-coupon converts. Rule 8 was executed as "blitz-style raising, utility-style spending." - Inflection points to watch quarterly: ① the Piketon financing structure's finalized disclosure — resolving the contingent ② DOE waiver renewals and supply-license extensions — the survival metric ③ DOE task-order milestones and Piketon construction progress — the only path to measured commercial HALEU delivery. Atlas v2 classifies this as pre-ignition, conditional. - One-line risk: the Russia to be replaced is the supplier — if the waiver breaks before domestic production reaches cruising altitude (2029), the company has nothing to sell and nothing to buy.

*Translated from the Korean edition (2026-10-15). For education and research purposes only. Not a recommendation to buy, sell, or hold any security.*

Next earnings

Nov 4, 2026 · Expected

Coverage

As of October 2026 · Model v1.0 (frozen) · Confidence: High (listed, SEC filings) · Not investment advice — a scholar's assessment.

BlitzLab scores businesses against a scholar’s standard — not investment advice. No price targets, no buy/sell recommendations. Figures are from SEC filings (XBRL) as labeled in the source scorecard.